A clinical trial to investigate efficacy and safety of continous treatment with bevacizumab together with chemotherapy in elderly patients with metastasized colorectal cancer

Primary objectives: To evaluate the feasibility of continous treatment with bevacizumab beyond disease progression in an elderly community based patient population by assessment of overall survival
Primary endpoints: Overall survival from time of enrolment